Summary
GlobalData's clinical trial report, “Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2018" provides an overview of Vulvovaginal Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Vulvovaginal Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Scynexis Inc
Bayer AG
Viamet Pharmaceuticals Holdings, LLC
Cidara Therapeutics Inc
Pfizer Inc
NovaDigm Therapeutics Inc
Mirati Therapeutics Inc
Johnson & Johnson
Chr. Hansen Holding A/S
Biose
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Vulvovaginal Candidiasis to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Vulvovaginal Candidiasis to Infectious Disease Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Vulvovaginal Candidiasis Therapeutics Clinical Trials 34
Prominent Drugs 36
Latest Clinical Trials News on Vulvovaginal Candidiasis 37
Jul 10, 2018: SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis 37
Clinical Trial Profile Snapshots 39
Appendix 121
Abbreviations 121
Definitions 121
Research Methodology 122
Secondary Research 122
About GlobalData 122
Contact Us 123
Source 123
List of Tables
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials by Region, 2018* 7
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Vulvovaginal Candidiasis Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Vulvovaginal Candidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 17
Vulvovaginal Candidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Vulvovaginal Candidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Vulvovaginal Candidiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 22
Vulvovaginal Candidiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Vulvovaginal Candidiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Vulvovaginal Candidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
List of Figures
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Vulvovaginal Candidiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Vulvovaginal Candidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
Vulvovaginal Candidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Vulvovaginal Candidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Vulvovaginal Candidiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 21
Vulvovaginal Candidiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Vulvovaginal Candidiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Vulvovaginal Candidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Vulvovaginal Candidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Vulvovaginal Candidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 122
